The antimicrobial peptide cathelicidin is critical for the development of Th17 responses in severe inflammatory disease (2022)

First Author: Smith K

Attributed to: Do adult human oligodendrocytes remyelinate poorly and can we change this to better treat progressive multiple sclerosis? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.01.27.477976

Publication URI: http://dx.doi.org/10.1101/2022.01.27.477976

Type: Preprint